SS
PACB icon

Steve Schonfeld’s Pacific Biosciences PACB Stock Holding History

Steve Schonfeld’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-655,885
Closed -$1.12M – 2283
2024
Q3 		$1.12M Buy
+655,885
New +$1.08M 0.01% 1126
2024
Q2 		– Sell
-268,245
Closed -$1.01M – 2459
2024
Q1 		$1.01M Buy
268,245
+116,869
+77% +$684K 0.01% 1224
2023
Q4 		$1.48M Sell
151,376
-129,124
-46% -$1.06M 0.01% 904
2023
Q3 		$2.34M Sell
280,500
-96,800
-26% -$1.11M 0.02% 777
2023
Q2 		$5.02M Buy
377,300
+165,962
+79% +$2.02M 0.04% 486
2023
Q1 		$2.45M Buy
211,338
+156,638
+286% +$1.56M 0.02% 636
2022
Q4 		$447K Sell
54,700
-32,425
-37% -$279K ﹤0.01% 1590
2022
Q3 		$505K Buy
+87,125
New +$500K ﹤0.01% 1734
2020
Q1 		– Sell
-280,960
Closed -$1.45M – 1419
2019
Q4 		$1.45M Buy
+280,960
New +$1.43M 0.04% 405
2017
Q1 		– Sell
-10,000
Closed -$38K – 697
2016
Q4 		$38K Buy
+10,000
New +$72.7K ﹤0.01% 527
2016
Q3 		– Sell
-41,859
Closed -$295K – 505
2016
Q2 		$295K Buy
41,859
+31,859
+319% +$291K 0.07% 318
2016
Q1 		$85K Buy
+10,000
New +$98.3K 0.03% 289

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's PACB Position: Q4 2024 in Review

Steve Schonfeld sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 655,885 shares — an estimated $1.12M sold.

Steve Schonfeld first reported a position in PACB in Q1 2016 and held it in 12 quarters. The position peaked at $5.02M in Q2 2023. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • Steve Schonfeld reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • Steve Schonfeld sold 655,885 Pacific Biosciences shares in Q4 2024, an estimated $1.12M.
  • Steve Schonfeld first reported a position in Pacific Biosciences in Q1 2016 and held it in 12 quarters.
  • Steve Schonfeld's Pacific Biosciences position peaked at $5.02M in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.